A lack of coenzyme A triggers a debilitating neurological disorder that strikes young children. St. Jude researchers have found a new drug that may facilitate CoA production and treat the disease.
Read More
We are concerned by evidence that obese people may not be adequately protected by influenza vaccines and likely to shed more of the virus for longer periods. Worldwide, over 650 million adults are obese. Is this one reason we are seeing more severe disease and less effective flu vaccines?
Read MoreInfectious diseases researchers Hana Hakim, Jason Rosch and their team sequenced gut microbiome bacteria to help predict the risk of infections during chemotherapy for children with acute lymphoblastic leukemia.
Read More
Normal housekeeping cell turns against host cancer cells when cellular process is turned off.
Read More
This new algorithm may expose the genetic origins of cancer
Read More
BOK was found to be a protein key in signaling a cancer cell to kill itself.
Read More
Learn about chronic pain in pediatric cancer survivors and a new model that shows potential pathways to chronic pain across the cancer trajectory.
Read More
Learn how this newly approved cancer drug scored high patient response rates by inhibiting a rare chromosomal abnormality that drives tumor growth.
Read More
This new statistical method identifies secondary traits that can be used to provide a broader genomic landscape and identify the genetic origins of diseases.
Read MoreA St. Jude lab identified a flu virus mutation that could lead to more effective treatments.
Read More
Immune response regulation enzyme holds key to possible cancer treatment.
Read More
What is the potential human cost of omitting whole-genome sequencing in pediatric cancer diagnoses? St. Jude G4K study answers that question.
Read More
